510(k) K142660
K142660 is an FDA 510(k) premarket notification submitted by LeMaitre Vascular, Inc. for the device "Antegrade LeMills Valvulotome". The FDA issued a decision of Substantially Equivalent on October 17, 2014. The device falls under product code MGZ (Valvulotome), a Class II device regulated under 21 CFR 870.4885. LeMaitre Vascular, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 17, 2014
- Date Received
- September 18, 2014
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Valvulotome
- Device Class
- Class II
- Regulation Number
- 870.4885
- Review Panel
- CV
- Submission Type